pgen.1011017.s010.xlsx (11.34 kB)
Survival summary of LUAD and LUSC patients before adjusting thresholds.
dataset
posted on 2023-11-21, 18:40 authored by Chaohao Li, Derek B. Allison, Daheng He, Fengyi Mao, Xinyi Wang, Piotr Rychahou, Ibrahim A. Imam, Yifan Kong, Qiongsi Zhang, Yanquan Zhang, Jinghui Liu, Ruixin Wang, Xiongjian Rao, Sai Wu, B. Mark Evers, Qing Shao, Chi Wang, Zhiguo Li, Xiaoqi LiuSurvival summary of LUAD and LUSC patients before adjusting thresholds.
History
Usage metrics
Categories
Keywords
type 2 deiodinaseseq analyses revealimportant transcription factordeiodinase inhibitor disruptsaryl hydrocarbon receptormultiple cancer typeslike kinase 1enhanced metastatic potentialdio2 converts tetraiodothyroninexlink "> metastasisvivo experiments demonstratelung cancer remainluad via dio2plk1 phosphorylates ahrplk1 promotes metastasislung cancerthreonine kinasemetastatic eventslung adenocarcinomaplk1 ),luad metastasiswhereas depletiontwo factorstaking togethert4 promotessubsequent activationresults identifyoncogene promotingmesenchymal transitionmajor causeahr ),
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC